US 4,336,200 A · 17.alpha.-Acyloxy-5.beta.-corticoids

Abstract

17.alpha.-Acyloxy-5.beta.-pregnanes (I) and 17.alpha.-acyloxy-5.alpha.-pregnanes (IV) have an excellent activity split providing high topical antiinflammatory activity with very low systemic side effects.

Claims1

Dependent claims

21-Ch loro-6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.beta.-methy l-5.beta.-pregnane-3,20-dione 17-propionate.

Dependencies are inferred from the claim text.

Facts

Application

06/229,257Filed 28 Jan 1981 · continuation in part

Priority

31 Jan 1980

Granted

22 Jun 1982

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07J 7/0055
Substituted in position 16: by a saturated or unsaturated hydrocarbon group
C07J 5/0053
Substituted in position 17 alfa: not substituted in position 16
C07J 5/0076
By a saturated or unsaturated hydrocarbon group: by an alkyl group
C07J 7/0045
Substituted in position 17 alfa: not substituted in position 16

17.alpha.-Acyloxy-5.beta.-corticoids

Life of this patent

Abstract

Claims1

17.alpha.-Acyloxy-5.beta.-corticoids

Life of this patent

Abstract

Claims1